These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9710952)
1. Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. II. Identification of urinary and fecal metabolites. Parent RA; Paust DE; Schrimpf MK; Talaat RE; Doane RA; Caravello HE; Lee SJ; Sharp DE Toxicol Sci; 1998 Jun; 43(2):110-20. PubMed ID: 9710952 [TBL] [Abstract][Full Text] [Related]
2. Metabolism and distribution of [2,3-14C]acrolein in Sprague-Dawley rats. Parent RA; Caravello HE; Sharp DE J Appl Toxicol; 1996; 16(5):449-57. PubMed ID: 8889798 [TBL] [Abstract][Full Text] [Related]
3. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. Cossum PA; Sasmor H; Dellinger D; Truong L; Cummins L; Owens SR; Markham PM; Shea JP; Crooke S J Pharmacol Exp Ther; 1993 Dec; 267(3):1181-90. PubMed ID: 8166890 [TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat. Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226 [TBL] [Abstract][Full Text] [Related]
5. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs. Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ethylene glycol. II. Tissue distribution, dose-dependent elimination, and identification of urinary metabolites following single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats and CD-1 mice. Frantz SW; Beskitt JL; Grosse CM; Tallant MJ; Dietz FK; Ballantyne B Xenobiotica; 1996 Nov; 26(11):1195-220. PubMed ID: 8948094 [TBL] [Abstract][Full Text] [Related]
7. Dose responses for the formation of hemoglobin adducts and urinary metabolites in rats and mice exposed by inhalation to low concentrations of 1,3-[2,3-(14)C]-butadiene. Booth ED; Kilgour JD; Watson WP Chem Biol Interact; 2004 Mar; 147(2):213-32. PubMed ID: 15013822 [TBL] [Abstract][Full Text] [Related]
8. Disposition of [14C]velnacrine maleate in rats, dogs, and humans. Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382 [TBL] [Abstract][Full Text] [Related]
9. Identification of circulatory and excretory metabolites of meisoindigo in rat plasma, urine and feces by high-performance liquid chromatography coupled with positive electrospray ionization tandem mass spectrometry. Huang M; Lee YS; Ho PC Rapid Commun Mass Spectrom; 2010 Mar; 24(6):729-41. PubMed ID: 20169560 [TBL] [Abstract][Full Text] [Related]
10. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats. Timchalk C; Smith FA; Bartels MJ Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263 [TBL] [Abstract][Full Text] [Related]
11. Tissue distribution and elimination of N-methyl-N-2,4,6-tetranitroaniline (tetryl) in rats. Myers SR; Spinnato JA Arch Toxicol; 2007 Dec; 81(12):841-8. PubMed ID: 17680234 [TBL] [Abstract][Full Text] [Related]
12. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats. Johnson KA; Prakash C Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349 [TBL] [Abstract][Full Text] [Related]
13. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans. Prakash C; Kamel A; Gummerus J; Wilner K Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of clenbuterol in rats. Zalko D; Debrauwer L; Bories G; Tulliez J Drug Metab Dispos; 1998 Sep; 26(9):891-9. PubMed ID: 9733668 [TBL] [Abstract][Full Text] [Related]
15. Metabolism and disposition of 1-bromopropane in rats and mice following inhalation or intravenous administration. Garner CE; Sumner SC; Davis JG; Burgess JP; Yueh Y; Demeter J; Zhan Q; Valentine J; Jeffcoat AR; Burka LT; Mathews JM Toxicol Appl Pharmacol; 2006 Aug; 215(1):23-36. PubMed ID: 16513153 [TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution, metabolism, and excretion of atevirdine in the rat. Chang M; Sood VK; Wilson GJ; Kloosterman DA; Sanders PE; Schuette MR; Judy RW; Voorman RL; Maio SM; Slatter JG Drug Metab Dispos; 1998 Oct; 26(10):1008-18. PubMed ID: 9763407 [TBL] [Abstract][Full Text] [Related]
17. Disposition and metabolism of radiolabeled casopitant in humans. Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128 [TBL] [Abstract][Full Text] [Related]
18. Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage. Arfsten DP; Johnson EW; Wilfong ER; Jung AE; Bobb AJ Cutan Ocul Toxicol; 2007; 26(2):113-34. PubMed ID: 17612979 [TBL] [Abstract][Full Text] [Related]
19. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites. Prakash C; Cui D Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030 [TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS. Prakash C; Soliman V Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]